Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2311-2008

Stryker Biotech OP- 1 Implant is indicated for use as an alternative to autograft in recalcitrant long bone...

Stryker Biotech / initiated 2008-06-24 / Terminated / root cause: labeling and UDI

Stryker Biotech began a recall of Stryker Biotech OP- 1 Implant is indicated for use as an alternative to autograft in recalcitrant long bone nonunions where use of autograft is unfeasible and... on . The reason FDA records is "Product Package Insert misprint-text offset". As of , the recall status on record is Terminated, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-2311-2008
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Stryker Biotech
Product
Stryker Biotech OP- 1 Implant is indicated for use as an alternative to autograft in recalcitrant long bone nonunions where use of autograft is unfeasible and alternative treatments have failed. Catalog Number: 100-25
Product code
MPW Filler, Recombinant Human Bone Morphogenetic Protein, Collagen Scaffold, Osteoinduction
Reason for recall
Product Package Insert misprint-text offset
Root cause tag
labeling and UDI
FDA root cause
Error in labeling
Action
Stryker Biotech notified by letter dated June 24, 2008 via UPS Certified Mail. Physician letters were mailed 30 Jun 2008 and IRB letters were mailed July 01, 2008; letters included a correctly printed package insert. Contact Judith Sernatinger at 508-416-5200 if you have questions.
Quantity in commerce
803 units
Distribution
Nationwide
Product codes and lots
Lots Numbers: FC0803004, FC0803005, FC0804002, FC0804007, FCO804010, FC0805002, FC0805003, and FC0805004